Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease

Journal of Pediatric Hematology/Oncology

Volumn 18, Issue 3, 1996, Pages 257-261

  Williams, Laura L ^a,b   Wilimas, Judith A ^a   Harris, Sylvia C ^a   Day, Sara W ^a   Dancy, Rhonda M ^a   Wang, Winfred C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

Outpatient therapy; Pneumococcal sepsis; Sickle cell disease

Indexed keywords

CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ACUTE GASTROENTERITIS; ANTIBIOTIC THERAPY; ARTICLE; BODY TEMPERATURE; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; FEVER; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; OUTPATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SICKLE CELL ANEMIA; UPPER RESPIRATORY TRACT INFECTION; URINE CULTURE; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ANEMIA, SICKLE CELL; ANTI-INFECTIVE AGENTS; BACTEREMIA; BACTERIAL INFECTIONS; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HUMANS; INFANT; MALE; OUTPATIENTS; PATIENT COMPLIANCE;

EID: 0029887216     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199608000-00004     Document Type: Article

References (16)

1. Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr 1986;109:579-85.
2. Buchanan GR, Smith SJ. Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia. Am J Dis Child 1986;140:428-32.
3. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Pediatrics 1989;84:500-8.
4. Vichinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol 1991;28:220-6.
5. Frenkel LD. Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children. Pediatrics 1988;82:486-91.
6. Chadwick EG, Connor EM, Shulman ST, Yogev R. Efficacy of ceftriaxone in treatment of serious childhood infections. J Pediatr 1983;103:141-5.
7. Wilimas JA, Flynn PM, Harris S, et al. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease. N Engl J Med 1993;329:472-6.
8. Hussar DA. Importance of patient compliance in effective antimicrobial therapy. Pediatr Infect Dis J 1987;6:971-5.
9. Day S, Brunson G, Wang W. A successful education program for parents of infants with newly diagnosed sickle cell disease. J Pediatr Nurs 1992;7:52-7.
10. Rogers ZR, Morrison RA, Vedro DA, Buchanan GR. Outpatient management of febrile illness in infants and young children with sickle cell anemia. J Pediatr 1990;117:736-9.
11. Rodriguez WJ, Khan W, Sait T, et al. Cefixime vs. cefaclor in the treatment of acute otitis media in children: a randomized, comparative study. Pediatr Inject Dis J 1993;12:70-4.
12. Barry AL, Jones RN. Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates. Pediatr Infect Dis J 1987;6:954-7.
13. Woods G, Wang W, Jorgensen J, Waclawiw M. Influence of penicillin prophylaxis in children with sickle cell disease on the antimicrobial susceptibility of S. pneumoniae [Abstract 275]. In: Proceedings of the National Sickle Cell Disease Program. Vol. 20. 1995:275.
14. Faulkner R, Yacubi A, Barone JS, et al. Pharmacokinetic profile of cefixime in man. Pediatr Infect Dis J 1987;6:963-70.
15. Buchanan GR, Siegel JD, Smith SJ, DePasse BM. Oral pencillin prophylaxis in children with impaired splenic function: a study of compliance. Pediatrics 1982;70:926-30.
16. Rodewald LE, Pichichero ME. Compliance with antibiotic therapy: a comparison of deuterium oxide tracer, urine bioassay, bottle weights, and parental reports. J Pediatr 1993;123:143-7.